This topic contains a solution. Click here to go to the answer

Author Question: The nurse becomes aware of inadequate insulin coverage in a patient with diabetes mellitus type 1 ... (Read 19 times)

ENagel

  • Hero Member
  • *****
  • Posts: 540
The nurse becomes aware of inadequate insulin coverage in a patient with diabetes mellitus type 1 when the patient exhibits:
 
  a. diminished urine output.
  b. ketones in the urine.
  c. shallow and slow respirations.
  d. extreme diaphoresis.

Question 2

The nurse suspects that the pale edematous listless diabetic patient who has a blood urea nitrogen (BUN) level of 35 mg/dl and a creatinine level of 4 mg/dl to have:
 
  a. diverticulitis.
  b. congestive heart failure.
  c. chronic renal failure.
  d. benign prostatic hypertrophy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raili21

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

ANS: B

Answer to Question 2

ANS: C




ENagel

  • Member
  • Posts: 540
Reply 2 on: Jul 11, 2018
Thanks for the timely response, appreciate it


sultana.d

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library